LLY
Eli Lilly and Company
1,142.90$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -114.2% | – | +25.7% | +153.2% | -33.4% | -32.7% | +85.3% | +186.2% | -63.5% | +65.4% | +100.5% | – | |
| – | -5.7% | +3.3% | +3.4% | +12.6% | +3.9% | -4.5% | +3.4% | -1.8% | +24.6% | -13.1% | +4.9% | – | |
| – | -44.2% | +32.6% | +32.4% | -36.9% | +6.5% | +8.3% | +20.4% | -18.4% | -9.9% | +18.3% | +24.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -499.9% | – | – | – | – | – | – | – | -404.1% | – | – | – | |
| – | -58.7% | -40.3% | +42.2% | +197.3% | -58.1% | +87.0% | -44.8% | -87.6% | +1,037.4% | -8.7% | +26.1% | – | |
| – | -5.1% | -59.7% | +86.7% | +82.1% | -52.0% | +74.6% | -45.3% | +62.5% | -6.0% | +39.7% | +293.2% | – | |
| – | +0.2% | +14.8% | +0.3% | -0.2% | -0.2% | +15.2% | +0.1% | -0.1% | +0.0% | +15.1% | -0.1% | – | |
| – | – | -100.0% | – | – | +360.4% | -41.6% | -42.3% | +2.3% | +112.9% | +56.3% | -32.0% | – | |
| – | – | – | – | – | +62.2% | +51.6% | -82.1% | +217.0% | -100.0% | – | +1,029.5% | – | |
| – | +519.7% | -108.8% | – | -86.4% | -206.7% | – | -190.2% | – | -642.1% | +20.5% | – | – | |
| – | – | -181.9% | – | -81.0% | -169.2% | – | – | +2,170.3% | -139.3% | – | – | – | |
| – | – | – | -64.7% | -823.8% | – | -320.3% | – | +571.2% | -92.1% | +343.6% | +158.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.